Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Voodoo who wrote (154920)	3/21/2020 8:46:49 AM
From: sense	Read Replies (1) \| Respond to of 217931

Wikipedia says: "As with other quinoline antimalarial drugs, the mechanism of action of quinine has not been fully resolved." I think that's right. I don't find a find a difficulty in the explanation of the anti-malarial functions in de-crystalization of the heme byproducts... sustaining their toxicity... but I find the explanation of the modification of pH a bit unsatisfying. Read the articles on the gating of Zn concentrations, which is pretty convincing science... I expect that, along with accelerated trials... we'll probably see more basic science work done to try to better elucidate the functions that inhibit RNA synthase ? Stopping viral replication... if done early, or done at a high enough level, clearly could be a big difference maker... If it works, knowing how it works will be key to generating "better" more quickly ? It's likely that having sparked this work... we'll break the spell numbing minds into thinking... "its a virus, and there's not much we can do about those"?